This antiviral drug could eliminate COVID-19 by day 3 of treatment
Scientists found that people taking the new anti-COVID drug molnupiravir eliminate SARS-CoV-2 virus by day three of starting therapy, while many participants who received...
People with ‘hybrid immunity’ have best COVID-19 protection
Scientists found that people with the "hybrid immunity" of having been both fully vaccinated and previously infected with COVID-19 have the strongest protection against...
Some people with asthma may have greater COVID-19 risk
Scientists from Imperial College London and elsewhere found that children and adults with asthma that is severe or poorly controlled are at greater risk...
After COVID-19, watch for these potential heart and brain problems
COVID-19 was full of surprises early on, causing mild problems in the short term for some people and serious complications for others.
Long term, it...
Any booster strategy is better than single J&J vaccine to prevent severe COVID-19
Scientists from the U.S. Centers for Disease Control and Prevention compared booster strategies for the millions of people who have received Johnson and Johnson...
Unhealthy lifestyles may increase your risk of severe COVID-19
Scientists from the University of Glasgow found unhealthy lifestyles are linked to a higher risk of severe COVID-19.
The research is published in BMC Infectious...
Second booster approved as option for additional protection against COVID-19
On March 29 the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) approved the use of a...
Diabetes risk increases after COVID-19, study finds
Scientists from the VA Saint Louis Health Care System found the risk of diabetes is increased for people after the COVID-19 infection.
The research is...
Lung damage may persist long after COVID-19 infection
A new study from Innsbruck Medical University found some people recovering from COVID-19 pneumonia have CT evidence of damage to their lungs that persists...
FDA approves second COVID-19 vaccine booster for these people
Today, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people...